Will UnitedHealth Stock Recover?
Shares of embattled health insurance giant UnitedHealth (NYSE:UNH) plummeted by…
Sell
13
INSP Quote, Financials, Valuation and Earnings
Last price:
$59.76
Seasonality move
:
-5.67%
Day range:
$65.37 - $68.64
52-week range:
$64.46 - $197.75
Dividend yield:
0%
P/E ratio:
46.79x
P/S ratio:
2.32x
P/B ratio:
2.97x
Volume:
2.4M
Avg. volume:
1.3M
1-year change:
-62.93%
Market cap:
$2B
Revenue:
$802.8M
EPS (TTM):
$1.46
Analysts' Opinion
-
Consensus RatingInspire Medical Systems, Inc. has received a consensus rating of Hold. The company's average rating is a Hold based on 6 Buy ratings, 9 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $124.40, Inspire Medical Systems, Inc. has an estimated upside of 82.38% from its current price of $68.21.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $81.00 representing 100% downside risk from its current price of $68.21.
Fair Value
-
According to the consensus of 15 analysts, Inspire Medical Systems, Inc. has 82.38% upside to fair value with a price target of $124.40 per share.
INSP vs. S&P 500
-
Over the past 5 trading days, Inspire Medical Systems, Inc. has underperformed the S&P 500 by -0.16% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Inspire Medical Systems, Inc. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Inspire Medical Systems, Inc. has grown year-over-year revenues for 21 quarters straight. In the most recent quarter Inspire Medical Systems, Inc. reported revenues of $224.5M.
Earnings Growth
-
Inspire Medical Systems, Inc. earnings have been falling on a year-over-year basis for 2 quarters in a row. In the most recent quarter Inspire Medical Systems, Inc. reported earnings per share of $0.34.
Enterprise value:
1.7B
EV / Invested capital:
--
Price / LTM sales:
2.32x
EV / EBIT:
46.07x
EV / Revenue:
1.92x
PEG ratio (5yr expected):
1.32x
EV / Free cash flow:
17.12x
Price / Operating cash flow:
20.74x
Enterprise value / EBITDA:
34.29x
Gross Profit (TTM):
$749.5M
Return On Assets:
5.65%
Net Income Margin (TTM):
5.05%
Return On Equity:
6.62%
Return On Invested Capital:
6.32%
Operating Margin:
4.3%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Income Statement | ||||||
| Revenue | $570.2M | $755.6M | $882.6M | $203.2M | $224.5M | |
| Gross Profit | $479.5M | $640.5M | $749.5M | $170.8M | $192.7M | |
| Operating Income | -$49.9M | $13.5M | $36.7M | $14.3M | $9.6M | |
| EBITDA | -$47M | $18.4M | $49.3M | $16.2M | $13.3M | |
| Diluted EPS | -$1.13 | $1.08 | $1.46 | $0.60 | $0.34 | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $255.5M | $495.5M | $569.6M | $582.5M | $586.5M | |
| Total Assets | $278.9M | $527.5M | $639.5M | $796.2M | $807.7M | |
| Current Liabilities | $33.6M | $49.3M | $70M | $74.3M | $110.8M | |
| Total Liabilities | $58.6M | $57.3M | $95.3M | $99.6M | $141.3M | |
| Total Equity | $220.3M | $470.2M | $544.2M | $696.6M | $666.5M | |
| Total Debt | $31M | $7.9M | $25.2M | $25.2M | $30.3M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $26.7M | $78.3M | $133.7M | $52.3M | $68.5M | |
| Cash From Investing | -$146M | -$268.6M | $37.1M | -$103M | -$11.6M | |
| Cash From Financing | $31.4M | $7.6M | -$205.3M | $9.9M | -$51.1M | |
| Free Cash Flow | $8.1M | $38.2M | $98.8M | $44.3M | $58.1M | |
INSP
Sector
Market Cap
$2B
$23.4M
Price % of 52-Week High
34.49%
48.88%
Dividend Yield
0%
0%
Shareholder Yield
8.59%
-1.64%
1-Year Price Total Return
-62.93%
-21.81%
Beta (5-Year)
0.740
0.504
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Sell
Level
$68.47
200-day SMA
Sell
Level
$106.21
Bollinger Bands (100)
Sell
Level
70.87 - 110.87
Chaikin Money Flow
Buy
Level
5.4M
20-day SMA
Sell
Level
$78.99
Relative Strength Index (RSI14)
Sell
Level
29.43
ADX Line
Sell
Level
33.95
Williams %R
Buy
Level
-81.0415
50-day SMA
Sell
Level
$98.35
MACD (12, 26)
Sell
Level
-8.23
25-day Aroon Oscillator
Sell
Level
-80
On Balance Volume
Neutral
Level
2.2M
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (29.3108)
Buy
CA Score
(Annual)
Level (1.7849)
Buy
Beneish M-Score
(Annual)
Level (-2.9238)
Sell
Momentum Score
Level (2)
Buy
Ohlson Score
Level (-4.2291)
Buy
Piotroski F Score
(Annual)
Level (7)
Buy
Quality Ratio Score
Level (9)
Buy
Fundamental Score
Level (6)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Inspire Medical Systems, Inc. is a medical technology company, which focuses on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea. The firm offers inspire therapy, which consists of a remote control and implantable components that includes pressure sensing lead, a neurostimulator, and a stimulation lead. It operates through the United States and All Other Countries geographical segments. The company was founded by Timothy P. Herbert in November 2007 and is headquartered in Golden Valley, MN.
Stock Forecast FAQ
In the current month, INSP has received 6 Buy ratings 9 Hold ratings, and 0 Sell ratings. The INSP average analyst price target in the past 3 months is $124.40.
-
Where Will Inspire Medical Systems, Inc. Stock Be In 1 Year?
According to analysts, the consensus estimate is that Inspire Medical Systems, Inc. share price will rise to $124.40 per share over the next 12 months.
-
What Do Analysts Say About Inspire Medical Systems, Inc.?
Analysts are divided on their view about Inspire Medical Systems, Inc. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Inspire Medical Systems, Inc. is a Sell and believe this share price will drop from its current level to $81.00.
-
What Is Inspire Medical Systems, Inc.'s Price Target?
The price target for Inspire Medical Systems, Inc. over the next 1-year time period is forecast to be $124.40 according to 15 Wall Street analysts, 6 of them rate the stock a Buy, 0 rate the stock a Sell, and 9 analysts rate the stock a Hold.
-
Is INSP A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Inspire Medical Systems, Inc. is a Hold. 9 of 15 analysts rate the stock a Hold at this time.
-
How Can I Buy Shares Of INSP?
You can purchase shares of Inspire Medical Systems, Inc. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Inspire Medical Systems, Inc. shares.
-
What Is The Inspire Medical Systems, Inc. Share Price Today?
Inspire Medical Systems, Inc. was last trading at $59.76 per share. This represents the most recent stock quote for Inspire Medical Systems, Inc.. Yesterday, Inspire Medical Systems, Inc. closed at $68.21 per share.
-
How To Buy Inspire Medical Systems, Inc. Stock Online?
In order to purchase Inspire Medical Systems, Inc. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Related Companies
Get INSP Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
INSP
Sector
P/E ratio
46.79x
23.34x
PEG ratio
1.32x
-0.01x
P/B ratio
2.97x
1.72x
Price / LTM sales
2.32x
1.51x
Growth Metrics
INSP
Sector
Revenue growth
10.49%
3.21%
Earnings growth
-44.44%
10.12%
Revenue (5-year growth)
57.8%
6.27%
Earnings forecast
$0.68
-$0.19
Profitability
INSP
Sector
Profitability FY 2024
$679.8M
$2.7M
Return on invested capital
6.32%
-33.62%
Return on assets
5.65%
-29.68%
Return on equity
6.62%
-38.89%
Earnings Date
Last Earnings Date
Feb
11
Next Earnings Date
Feb
13
Estimated Next Earnings Date
May
15
Balance Sheet
INSP
Sector
Total cash
$322.6M
$25M
Short term investments
$295.4M
$23.9M
Total assets
$808.4M
$72.8M
Long term debt
$30.3M
$2.5M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Lumentum The Best Laser Stock to Buy?
Though certainly less well-known than the huge tech businesses that…
Is Planet Fitness Stock Undervalued?
Planet Fitness (NYSE:PLNT) has had a difficult 12 months, retreating…
Stock Ideas
Buy
56
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 65x
Buy
58
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Sell
40
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 29x
Alerts
Buy
91
TDC alert for Feb 12
Teradata Corp. [TDC] is down 11.64% over the past day.
Buy
67
DIOD alert for Feb 12
Diodes, Inc. [DIOD] is down 7.63% over the past day.
Buy
77
VRT alert for Feb 12
Vertiv Holdings Co. [VRT] is down 4.79% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
